Dennis Langer - 27 Aug 2026 Form 4/A - Amendment Insider Report for Quoin Pharmaceuticals Ltd. (QNRX)

Reporting relationship: Director
Issuer ticker: QNRX
Reported as of: 27 Aug 2026
Net transaction value: $0
SEC form: 4/A - Amendment
Accepted by SEC: 26 Oct 2026, 20:21:12 UTC
Original report date: 28 Aug 2026
Prior SEC filing: 06 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Dennis Langer

Filing notes and source

Key filing fact

Dennis Langer filed Form 4/A - Amendment for Quoin Pharmaceuticals Ltd. (QNRX) on 26 Oct 2026.

Key facts

This page summarizes Dennis Langer's Form 4/A - Amendment filing for Quoin Pharmaceuticals Ltd. (QNRX).
0 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 26 Oct 2026, 20:21.

Change

Previous filing in this sequence was filed on 06 Feb 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reporting Owners (1)

CIK 0001274225 Primary reporting owner

LANGER DENNIS

Relationship: Director
Address: C/O QUOIN PHARMACEUTICALS LTD.,, 42127 PLEASANT FOREST COURT, ASHBURN
Signature: /s/ Dennis Langer
Signature date: 26 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

QNRX holding

ADSs

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 49,687
Date: 27 Aug 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Ordinary Shares are represented by American Depositary Shares ("ADSs"). Each ADS represents thirty-five (35) ordinary shares of the Issuer.

Footnote F2

On August 28, 2026, the reporting person filed a Form 4 (the "Original Form 4") which inadvertently overstated in column 5 the number of shares directly owned by the reporting person following the reported transaction. This inadvertent overstatement has been corrected in this amended filing.